Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: J Clin Nurs. 2017 Oct 10;27(3-4):516–545. doi: 10.1111/jocn.14057

Table 1.

Cross-sectional Studies of Symptom Clusters in Heterogeneous Samples of Oncology Patients

Author, Year, Title, Purpose, and Design Sample Size, Patient Characteristics, Time of Symptom Assessment Symptom Assessment Instrument(s), Number of Symptoms on Instrument; Statistical Analysis Method, Symptom Dimension(s) Used to Create Symptom Clusters Number of Symptom Clusters, Specific Symptoms Within Each Cluster Strengths and Limitations
Chen et al., 2006

Title: Symptom Clusters in Cancer Patients

Purpose(s): To identify symptom clusters experienced by patients with various cancer diagnoses and validate the conceptual meanings of the identified clusters

Design: Cross-sectional
N=151
Mean age: 50.1 (SD=14.41), range: 18–79

Female: 40.4%
Inpatients: n=128
Outpatients: n=23

Diagnosis:
  • Hematologic: 27.8%

  • Liver cancer: 18.5%

  • Head/neck cancer: 11.9%

  • Colo-rectal: 9.9%

  • Breast: 9.3%

  • Lung: 6.0%

  • Gastric: 4.0%

  • Other: 12.6%

Treatment: 67% on CTX

Time of symptom assessment:
Range: 0–394 days; median of 24 days since cancer diagnosis
  • 0–30 - 54.7%

  • 31–60 - 13.1%

  • 61–90 - 5.1%

  • 91–180 - 15.3%

  • 181–394: 11.7%

Instrument(s):
MDASI: 13 items
Depression Subscale of the HADS-D: 14 items

Analysis:
EFA with principal axis factoring

Dimension(s):
Severity
3 symptom clusters identified:

Sickness symptoms: pain, fatigue, sleep disturbance, lack of appetite, drowsiness

GI symptoms: nausea, vomiting

Emotional symptoms: distress, sadness
Strengths:
Evaluated conceptual meanings of symptom clusters

Limitations:
MDASI assessed only 13 symptoms

Disease specific symptoms were not evaluated

Symptom clusters created using only symptom severity scores

Cross-sectional design

Primarily evaluated inpatients
Chen et al., 2007

Title: Cancer Symptom Clusters: A Validation Study

Purpose(s): To validate the 3 factor symptom structure by using CFA in a larger sample of cancer patients and to examine how 4 disease/treatment variables (diagnosis, disease stage, cancer treatment, hospitalization) and one outcome variable (functional status) were associated with the 3 symptom factors (sickness symptoms, GI symptoms, emotional symptoms)

Design: Cross-sectional
N=321
Mean age: 60.7 (SD=13.78), range: 22–97

Female: 54.5%
Outpatients: 76.9%

Diagnosis:
  • Breast: 29.0%

  • GI: 34.6%

  • Head/neck: 17.8%

  • Urogenital: 14.0%

  • Lung: 7.5%

  • Hematologic: 3.1%

  • Brain/CNS: 1.9%

  • Other: 2.2%

Treatment:
  • CTX: 53.0%

  • RT: 72.6%

Time of symptom assessment: 29.6 months after diagnosis
Instrument(s):
MDASI-T: 13 items

Analysis:
CFA with maximum likelihood estimation.

9 MDASI symptoms used to build the measurement model

Dimension(s):
Severity
3 symptom clusters identified:

Sickness symptoms: pain, fatigue, disturbed sleep, lack of appetite, drowsiness

GI symptoms: nausea, vomiting

Emotional symptoms: distress, sadness
Strengths
Evaluated relationships between symptom cluster “scores” and disease and treatment characteristics

Demonstrated that higher symptom cluster “scores” were associated with decreased functional status

Limitations:
Used only 9 symptoms from the MDASI-T

Heterogeneous cancer diagnoses

Cross-sectional design
Karabulu et al., 2010

Title: Symptom Clusters and Experiences of Patients with Cancer

Purpose(s): To characterize the prevalence and severity of symptoms in Turkish patients with cancer and describe the clustering symptoms

Design: Cross-sectional
N=287
Female: 44.3%

Diagnosis:
  • Digestive: 39.4%

  • Breast: 11.8%

  • Lung: 17.1%

  • Head/Neck: 12.9%

  • Leukemia: 13.6%

  • Gynecological: 5.2%

Treatment:
  • RT: 2.1%

  • CTX: 72.1%

  • RT+CTX: 8.0%

  • CTX+Surgery+RT: 15.3%

  • CTX+Surgery: 2.3%

Time of symptom assessment:
2.9 years after diagnosis
Instrument(s):
MDASI: 13 items

Analysis:
Hierarchical cluster analysis

Dimension(s):
Severity
Interference
3 symptom clusters identified:

Cluster 1: general activity, mood, work, relations with other people, walking, enjoyment of life.

Cluster 2: sleep disturbance, difficulty in remembering, pain, distress, sadness, fatigue, dry mouth, appetite loss

Cluster 3: nausea, vomiting, shortness of breath, numbness, drowsiness
Strengths:
First study in Turkish oncology patients
Relatively large sample size

Limitations:

Cross-sectional design

Inclusion of interference items in the symptom cluster analysis

Symptom clusters were not named

MDASI assesses only 13 items
Yamagishi, et al., 2009

Title: Symptom Prevalence and Longitudinal Follow-Up in Cancer Outpatients Receiving Chemotherapy

Purpose(s): To clarify the prevalence of physical symptoms and concerns among a representative sample of cancer patients receiving CTX in the outpatient setting; to evaluate symptom clusters in this study population and; to explore longitudinal change and the effects of physical symptoms on the DT

Design: Cross-sectional
N=462
Mean age: 62.0 (SD=11.0), range: 52–74
Female: 55%

Diagnosis:
  • Lung/chest: 33.0%

  • Breast: 25.0%

  • Colon/rectum: 14.0%

  • Stomach: 16.0%

  • Uterus/ovary: 7.1%

  • Pancreas/bile duct: 4.1%

  • Other: 1.7%

Treatment: CTX

Time of symptom assessment: At start of initial CTX
Instrument(s):
Investigators developed the instrument using 8 physical symptoms from the MDASI; presence or absence of oral problems, fever, and insomnia; overall rating of QOL from EORTC questionnaires; distress thermometer

Analysis:
Cluster analysis

Dimension(s):
Authors did not specify what items were included in the cluster analysis
4 symptom clusters identified:

Cluster 1: fatigue, somnolence

Cluster 2: pain, dyspnea, numbness

Cluster 3: nausea, appetite loss, constipation

Cluster 4: psychological distress
Strengths:
Large sample size

Single treatment at the induction of CTX

Limitations:
Cross-sectional study

Type of cluster analysis not specified

Heterogeneous cancer diagnoses

Symptom clusters not named

Unclear which symptoms and dimensions were included in the cluster analysis
Yates et al., 2015

Title: Differences in Composition of Symptom Clusters Between Older and Younger Patients

Purpose(s): To identify and compare symptom clusters in younger (<60 years) and older (≥60 years) patients undergoing cancer treatment

Design: Three combined studies:
Symptom Clusters Study:
Prospective, longitudinal
Fatigue, Pain, and Sleep Study:
Longitudinal
Symptom Prevalence Study:
Descriptive, cross-sectional
N=263 (<60 years), mean age: 50.3 (SD=7.7)
N=330 (≥60 years), mean age: 70.1 (SD=6.5)

Group mean age: 61.3

Female: 54.6%
Outpatients: 100%

Diagnosis (<60, ≥60):
  • Breast: 48.3%, 21.8%

  • Prostate: 11.0%, 37.9%

  • Lung: 11.4%, 14.5%

  • Lung: 29.3%, 25.8%

Treatment:
  • None: 13.3%, 17.3%

  • RT: 33.8%, 51.4%

  • CTX: 31.2%, 24.3%

  • CTX and RT: 21.7%, 7.0%

Time of symptom assessment:
For the longitudinal studies, at the time of recruitment into the study
Instrument(s):
MSAS: 32 items

ECOG: functional status rated by clinician (i.e., Australian study) on a 0 to 4 scale

KPS: functional status (i.e., U.S. study) on a 0 to 100 scale

ECOG: used for combined study on a 0 to 4 scale

Analysis:
Exploratory factor analysis

Dimension(s):
Occurrence
For patients <60 years: 7 symptom clusters were identified:

Treatment related: dry mouth, difficulty swallowing, SOB, lack of appetite, nausea, vomiting, lack of energy, change in food tastes, feeling dizzy, cough, weight loss, constipation, pain, feeling drowsy, mouth sores, feeling nervous, I do not look like myself, difficulty concentrating, feeling bloated

Mood/Cognitive: worrying, feeling sad, feeling nervous, feeling irritable, difficulty concentrating, lack of energy, difficulty sleeping, problems with sexual interest, I do not look like myself

Malaise: lack of energy, feeling drowsy, lack of appetite, nausea, difficulty concentrating, diarrhea, feeling bloated, feeling nervous, difficulty sleeping

Treatment related GI: vomiting, nausea, not itching

GU: problems with urination, problems with sexual interest

Hormonal: sweats, difficulty sleeping, pain, not weight loss

CTX toxicity: hair loss, change in food tastes, I do not look like myself, mouth sores, constipation, feeling bloated, swelling of arms/legs, dry mouth

For patients ≥60 years: 7 symptom clusters were identified:

Malaise: feeling drowsy, lack of energy, difficulty concentrating, difficulty sleeping, feeling nervous, feeling sad, feeling irritable, feeling dizzy, problems with sexual interest, sweats

Mood/Cognitive: worrying, feeling sad, feeling nervous, feeling irritable, lack of energy, difficulty concentrating, lack of appetite, nausea, feeling drowsy, change in food tastes, constipation, I do not look like myself, feeling bloated, numbness/tingling in hands/feet

Aerodigestive: SOB, cough, dry mouth, difficulty swallowing, lack of appetite, feeling bloated, feeling nervous, lack of energy, nausea, swelling of arms/legs, feeling dizzy, feeling sad, pain, feeling drowsy, difficulty sleeping

GU: problems with urination, diarrhea, problems with sexual interest, feeling irritable

Nutrition: weight loss, lack of appetite, constipation, change in food tastes, I do not look like myself, lack of energy, feeling drowsy, nausea

Aging related: difficulty swallowing, dry mouth, constipation, feeling drowsy, change in food tastes, nausea

CTX toxicity: skin changes, hair loss, I do not look like myself, swelling of arms/legs, feeling sad
Strengths:
First study to identify four core symptom clusters and differentiate between symptom clusters based on age groups

Found that those ≥60 years had consistently lower symptom occurrence rates

Identified that cancer treatment approaches may differ between older and younger patients

Large sample size

Combined three studies from two geographic regions

Limitations:
Only used one symptom dimension to create the clusters across the three studies

Included patients with metastatic disease which may have had an effect on the symptom experience

Excluded patients who had surgery

Race/ethnicity not identified

Abbreviations: CNS, Central Nervous System; CTX, chemotherapy; CFA, Confirmatory Factor Analysis; DT, Distress Thermometer; EORTC, European Organization for Research and Treatment of Cancer; EFA, Exploratory Factor Analysis; GI, gastrointestinal; HADS, Hospital Anxiety and Depression Scale; MDASI, MD Anderson Symptom Inventory; MDASI-T, MD Anderson Symptom Inventory-Taiwanese; MSAS, Memorial Symptom Assessment Scale; QOL, quality of life; RT, radiation therapy; SOB, shortness of breath; UGI, upper-gastrointestinal.